These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18792895)

  • 1. Discovery of NMDA glycine site inhibitors from the chemical universe database GDB.
    Nguyen KT; Syed S; Urwyler S; Bertrand S; Bertrand D; Reymond JL
    ChemMedChem; 2008 Oct; 3(10):1520-4. PubMed ID: 18792895
    [No Abstract]   [Full Text] [Related]  

  • 2. 3-(aminomethyl)piperazine-2,5-dione as a novel NMDA glycine site inhibitor from the chemical universe database GDB.
    Nguyen KT; Luethi E; Syed S; Urwyler S; Bertrand S; Bertrand D; Reymond JL
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3832-5. PubMed ID: 19394821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoMFA and homology-based models of the glycine binding site of N-methyl-d-aspartate receptor.
    Tikhonova IG; Baskin II; Palyulin VA; Zefirov NS
    J Med Chem; 2003 Apr; 46(9):1609-16. PubMed ID: 12699379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach.
    Mony L; Triballeau N; Paoletti P; Acher FC; Bertrand HO
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5552-8. PubMed ID: 20692832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
    Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
    J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of selective norbornane-type aspartate analogue inhibitors of the glutamate transporter 1 (GLT-1) from the chemical universe generated database (GDB).
    Luethi E; Nguyen KT; Bürzle M; Blum LC; Suzuki Y; Hediger M; Reymond JL
    J Med Chem; 2010 Oct; 53(19):7236-50. PubMed ID: 20812729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pyrrolinones as N-methyl-D-aspartate receptor antagonists.
    Poschenrieder H; Stachel HD; Höfner G; Mayer P
    Eur J Med Chem; 2005 Apr; 40(4):391-400. PubMed ID: 15804538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
    Lowe JA; Hou X; Schmidt C; David Tingley F; McHardy S; Kalman M; Deninno S; Sanner M; Ward K; Lebel L; Tunucci D; Valentine J; Bronk BS; Schaeffer E
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2974-6. PubMed ID: 19410451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity.
    Kawai M; Nakamura H; Sakurada I; Shimokawa H; Tanaka H; Matsumizu M; Ando K; Hattori K; Ohta A; Nukui S; Omura A; Kawamura M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5533-6. PubMed ID: 17768047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glycine site of the NMDA receptor--five years on.
    Kemp JA; Leeson PD
    Trends Pharmacol Sci; 1993 Jan; 14(1):20-5. PubMed ID: 8382885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular orbital differentiation of agonist and antagonist activity in the GlycineB-iGluR-NMDA receptor.
    Yosa J; Blanco M; Acevedo O; Lareo LR
    Eur J Med Chem; 2009 Jul; 44(7):2960-6. PubMed ID: 19243863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists.
    Gitto R; De Luca L; Ferro S; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
    Bioorg Med Chem; 2009 Feb; 17(4):1640-7. PubMed ID: 19157884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NMDA agonists and antagonists].
    Toki S
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1863-72. PubMed ID: 8210430
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of tricyclic heterocycle-tetraamine conjugates as potent NMDA channel blockers.
    Takayama H; Yaegashi Y; Kitajima M; Han X; Nishimura K; Okuyama S; Igarashi K
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4729-32. PubMed ID: 17624774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of α7-nicotinic receptor ligands by virtual screening of the chemical universe database GDB-13.
    Blum LC; van Deursen R; Bertrand S; Mayer M; Bürgi JJ; Bertrand D; Reymond JL
    J Chem Inf Model; 2011 Dec; 51(12):3105-12. PubMed ID: 22077916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17.
    Ruddigkeit L; van Deursen R; Blum LC; Reymond JL
    J Chem Inf Model; 2012 Nov; 52(11):2864-75. PubMed ID: 23088335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design.
    Liang GB; Qian X; Biftu T; Singh S; Gao YD; Scapin G; Patel S; Leiting B; Patel R; Wu J; Zhang X; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3706-10. PubMed ID: 18524582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
    Blum LC; Reymond JL
    J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.